Skip to main content
EQ
NASDAQ Life Sciences

Equillium Q2 Loss Narrows to $4.69M, Beats Estimates; New R&D Programs Advance

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$2.009
Mkt Cap
$127.085M
52W Low
$0.756
52W High
$3.54
52W Position info
166% above low
Off High info
43% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

EQ has more than doubled off its 52-week low of $0.756.

Summary

Equillium reported Q2 net loss of $4.69M, beating consensus of $5.91M, with loss per share of $0.04 vs $0.05 expected. The company also initiated IND-enabling development for EQ504 as an inhaled therapy and EQ302 for celiac disease, expanding its pipeline. Phase 1 EQ504 study is planned for Q4 2026 with data about six months later. Cash runway extends into 2029, consistent with prior guidance. This follows a reverse stock split approved in May and insider selling by the CSO in June, but the earnings beat and new R&D initiatives are fresh positive developments.

At the time of this announcement, EQ was trading at $2.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $127.1M. The 52-week trading range was $0.76 to $3.54. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

EQ - Latest Insights

EQ
Nov 12, 2026, 4:20 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $1.34
Real-time Price: $1.37 info
Change: +$0.030 (+2%) info
Market Cap: $106.199M info
EQ
Oct 26, 2026, 5:09 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.29
Real-time Price: $1.37 info
Change: +$0.080 (+6%) info
Market Cap: $106.199M info
EQ
Oct 26, 2026, 8:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.12
Real-time Price: $1.37 info
Change: +$0.2497 (+22%) info
Market Cap: $106.199M info
EQ
Oct 05, 2026, 5:06 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.42
Real-time Price: $1.37 info
Change: -$0.050 (-4%) info
Market Cap: $106.199M info
EQ
Oct 05, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.51
Real-time Price: $1.37 info
Change: -$0.140 (-9%) info
Market Cap: $106.199M info